Worth reading
63In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
2865000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
14th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price)
Who receives how much
Shares delivered during the month: 2,865,000 shares (2,865,000 new shares and 0 treasury shares transferred)
Nagasawa Makoto (長澤誠) (issued on 15 December 2023)
The lower thin line represents the existing number of shares to which these shares will be added.
発行済株式総数
2,865,000 shares delivered upon exercise; 113,264,569 shares issued and outstanding as of the end of the month preceding the applicable month (approximately 2.53%); exercise ratio subject to exercise restrictions: 8.34%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
12 June: ¥38.0. The exercise price was adjusted on 15 June 2026 pursuant to the exercise price adjustment clause. Adjusted price and floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 187,000; exercised during the month: 28,650; unexercised as of the end of the month preceding the applicable month: 33,150; unexercised as of the end of the applicable month: 4,500
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Announced on 13 November 2023: Issuance of the Series 11 through Series 13 Stock Acquisition Rights (with Exercise Price Adjustment Clause) and the Series 14 and Series 15 Stock Acquisition Rights (with Exercise Price Adjustment Clause) (issue price and amount: Not disclosed)
| Item | Details |
|---|---|
| Type of issuance or disposal | 14th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 2,865,000 shares (2,865,000 new shares and 0 treasury shares transferred) |
| Intended allottee | Nagasawa Makoto (長澤誠) (issued on 15 December 2023) |
| Dilution Rate | 2,865,000 shares delivered upon exercise; 113,264,569 shares issued and outstanding as of the end of the month preceding the applicable month (approximately 2.53%); exercise ratio subject to exercise restrictions: 8.34% |
| Total number of issued shares | 113,264,569 shares (as of the end of the month preceding the applicable month) → Not disclosed |
| Exercise price | 12 June: ¥38.0. The exercise price was adjusted on 15 June 2026 pursuant to the exercise price adjustment clause. Adjusted price and floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 187,000; exercised during the month: 28,650; unexercised as of the end of the month preceding the applicable month: 33,150; unexercised as of the end of the applicable month: 4,500 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Announced on 13 November 2023: Issuance of the Series 11 through Series 13 Stock Acquisition Rights (with Exercise Price Adjustment Clause) and the Series 14 and Series 15 Stock Acquisition Rights (with Exercise Price Adjustment Clause) (issue price and amount: Not disclosed) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of these stock acquisition rights in June 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.